732 - EASI 90 response sustained up to 38 weeks after lebrikizumab withdrawal despite negligible serum concentrations

732 - EASI 90 response sustained up to 38 weeks after lebrikizumab withdrawal despite negligible serum concentrations

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of dermatology (1951) 2024-08, Vol.191 (Supplement_2)
Hauptverfasser: Silverberg, Jonathan I, Bieber, Thomas, Eyerich, Kilian, Armstrong, April W, Nickoloff, Brian J, Natalie, Chitra R, Gallo, Gaia, Okragly, Angela, Xu, Chenjia, Moser, Brian, Rueda, Maria Jose, Elmaraghy, Hany, Uluckan, Ozge, Gudjonsson, Johann E
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_2
container_start_page
container_title British journal of dermatology (1951)
container_volume 191
creator Silverberg, Jonathan I
Bieber, Thomas
Eyerich, Kilian
Armstrong, April W
Nickoloff, Brian J
Natalie, Chitra R
Gallo, Gaia
Okragly, Angela
Xu, Chenjia
Moser, Brian
Rueda, Maria Jose
Elmaraghy, Hany
Uluckan, Ozge
Gudjonsson, Johann E
description
doi_str_mv 10.1093/bjd/ljae266.105
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_bjd_ljae266_105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_bjd_ljae266_105</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1093_bjd_ljae266_1053</originalsourceid><addsrcrecordid>eNqVj81KxDAURoMoWHXWbu8L1N40tGOXIiO61n1I29uZdNIfchOKPr0R5gVcfXDgO3CEeJT4JLFRRTv2hRsNlXWdQHUlMqnqKi-lUtciQ8R9jk2tbsUd84goFVaYibhXJeRwePn8gAbBE6_LzAQcORg7Uw9xhbCAeoaN6MxghkAeHLXenu1PnEwLmw2n3pvNOOjT3waCmY7OHm3rkol8nKBb5o7m4E2wyf8gbgbjmHaXvRfF2-Hr9T3v_MLsadCrt5Px31qi_qvTqU5f6hKo1P8fv7jWWwg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>732 - EASI 90 response sustained up to 38 weeks after lebrikizumab withdrawal despite negligible serum concentrations</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Silverberg, Jonathan I ; Bieber, Thomas ; Eyerich, Kilian ; Armstrong, April W ; Nickoloff, Brian J ; Natalie, Chitra R ; Gallo, Gaia ; Okragly, Angela ; Xu, Chenjia ; Moser, Brian ; Rueda, Maria Jose ; Elmaraghy, Hany ; Uluckan, Ozge ; Gudjonsson, Johann E</creator><creatorcontrib>Silverberg, Jonathan I ; Bieber, Thomas ; Eyerich, Kilian ; Armstrong, April W ; Nickoloff, Brian J ; Natalie, Chitra R ; Gallo, Gaia ; Okragly, Angela ; Xu, Chenjia ; Moser, Brian ; Rueda, Maria Jose ; Elmaraghy, Hany ; Uluckan, Ozge ; Gudjonsson, Johann E</creatorcontrib><identifier>ISSN: 0007-0963</identifier><identifier>EISSN: 1365-2133</identifier><identifier>DOI: 10.1093/bjd/ljae266.105</identifier><language>eng</language><ispartof>British journal of dermatology (1951), 2024-08, Vol.191 (Supplement_2)</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Silverberg, Jonathan I</creatorcontrib><creatorcontrib>Bieber, Thomas</creatorcontrib><creatorcontrib>Eyerich, Kilian</creatorcontrib><creatorcontrib>Armstrong, April W</creatorcontrib><creatorcontrib>Nickoloff, Brian J</creatorcontrib><creatorcontrib>Natalie, Chitra R</creatorcontrib><creatorcontrib>Gallo, Gaia</creatorcontrib><creatorcontrib>Okragly, Angela</creatorcontrib><creatorcontrib>Xu, Chenjia</creatorcontrib><creatorcontrib>Moser, Brian</creatorcontrib><creatorcontrib>Rueda, Maria Jose</creatorcontrib><creatorcontrib>Elmaraghy, Hany</creatorcontrib><creatorcontrib>Uluckan, Ozge</creatorcontrib><creatorcontrib>Gudjonsson, Johann E</creatorcontrib><title>732 - EASI 90 response sustained up to 38 weeks after lebrikizumab withdrawal despite negligible serum concentrations</title><title>British journal of dermatology (1951)</title><issn>0007-0963</issn><issn>1365-2133</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqVj81KxDAURoMoWHXWbu8L1N40tGOXIiO61n1I29uZdNIfchOKPr0R5gVcfXDgO3CEeJT4JLFRRTv2hRsNlXWdQHUlMqnqKi-lUtciQ8R9jk2tbsUd84goFVaYibhXJeRwePn8gAbBE6_LzAQcORg7Uw9xhbCAeoaN6MxghkAeHLXenu1PnEwLmw2n3pvNOOjT3waCmY7OHm3rkol8nKBb5o7m4E2wyf8gbgbjmHaXvRfF2-Hr9T3v_MLsadCrt5Px31qi_qvTqU5f6hKo1P8fv7jWWwg</recordid><startdate>20240808</startdate><enddate>20240808</enddate><creator>Silverberg, Jonathan I</creator><creator>Bieber, Thomas</creator><creator>Eyerich, Kilian</creator><creator>Armstrong, April W</creator><creator>Nickoloff, Brian J</creator><creator>Natalie, Chitra R</creator><creator>Gallo, Gaia</creator><creator>Okragly, Angela</creator><creator>Xu, Chenjia</creator><creator>Moser, Brian</creator><creator>Rueda, Maria Jose</creator><creator>Elmaraghy, Hany</creator><creator>Uluckan, Ozge</creator><creator>Gudjonsson, Johann E</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20240808</creationdate><title>732 - EASI 90 response sustained up to 38 weeks after lebrikizumab withdrawal despite negligible serum concentrations</title><author>Silverberg, Jonathan I ; Bieber, Thomas ; Eyerich, Kilian ; Armstrong, April W ; Nickoloff, Brian J ; Natalie, Chitra R ; Gallo, Gaia ; Okragly, Angela ; Xu, Chenjia ; Moser, Brian ; Rueda, Maria Jose ; Elmaraghy, Hany ; Uluckan, Ozge ; Gudjonsson, Johann E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1093_bjd_ljae266_1053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Silverberg, Jonathan I</creatorcontrib><creatorcontrib>Bieber, Thomas</creatorcontrib><creatorcontrib>Eyerich, Kilian</creatorcontrib><creatorcontrib>Armstrong, April W</creatorcontrib><creatorcontrib>Nickoloff, Brian J</creatorcontrib><creatorcontrib>Natalie, Chitra R</creatorcontrib><creatorcontrib>Gallo, Gaia</creatorcontrib><creatorcontrib>Okragly, Angela</creatorcontrib><creatorcontrib>Xu, Chenjia</creatorcontrib><creatorcontrib>Moser, Brian</creatorcontrib><creatorcontrib>Rueda, Maria Jose</creatorcontrib><creatorcontrib>Elmaraghy, Hany</creatorcontrib><creatorcontrib>Uluckan, Ozge</creatorcontrib><creatorcontrib>Gudjonsson, Johann E</creatorcontrib><collection>CrossRef</collection><jtitle>British journal of dermatology (1951)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Silverberg, Jonathan I</au><au>Bieber, Thomas</au><au>Eyerich, Kilian</au><au>Armstrong, April W</au><au>Nickoloff, Brian J</au><au>Natalie, Chitra R</au><au>Gallo, Gaia</au><au>Okragly, Angela</au><au>Xu, Chenjia</au><au>Moser, Brian</au><au>Rueda, Maria Jose</au><au>Elmaraghy, Hany</au><au>Uluckan, Ozge</au><au>Gudjonsson, Johann E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>732 - EASI 90 response sustained up to 38 weeks after lebrikizumab withdrawal despite negligible serum concentrations</atitle><jtitle>British journal of dermatology (1951)</jtitle><date>2024-08-08</date><risdate>2024</risdate><volume>191</volume><issue>Supplement_2</issue><issn>0007-0963</issn><eissn>1365-2133</eissn><doi>10.1093/bjd/ljae266.105</doi></addata></record>
fulltext fulltext
identifier ISSN: 0007-0963
ispartof British journal of dermatology (1951), 2024-08, Vol.191 (Supplement_2)
issn 0007-0963
1365-2133
language eng
recordid cdi_crossref_primary_10_1093_bjd_ljae266_105
source Oxford University Press Journals All Titles (1996-Current)
title 732 - EASI 90 response sustained up to 38 weeks after lebrikizumab withdrawal despite negligible serum concentrations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T08%3A25%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=732%20-%20EASI%2090%20response%20sustained%20up%20to%2038%20weeks%20after%20lebrikizumab%20withdrawal%20despite%20negligible%20serum%20concentrations&rft.jtitle=British%20journal%20of%20dermatology%20(1951)&rft.au=Silverberg,%20Jonathan%20I&rft.date=2024-08-08&rft.volume=191&rft.issue=Supplement_2&rft.issn=0007-0963&rft.eissn=1365-2133&rft_id=info:doi/10.1093/bjd/ljae266.105&rft_dat=%3Ccrossref%3E10_1093_bjd_ljae266_105%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true